ITERIS, INC.

2024 Q3 Form 10-Q Financial Statement

#000035086824000025 Filed on August 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $21.38M
YoY Change 6.92%
Cash & Equivalents $21.38M
Short-Term Investments
Other Short-Term Assets $3.666M
YoY Change -25.46%
Inventory $14.84M
Prepaid Expenses
Receivables $30.64M
Other Receivables $0.00
Total Short-Term Assets $78.91M
YoY Change 12.17%
LONG-TERM ASSETS
Property, Plant & Equipment $1.288M
YoY Change -2.05%
Goodwill $28.30M
YoY Change -0.14%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.084M
YoY Change 149.77%
Total Long-Term Assets $46.33M
YoY Change -3.54%
TOTAL ASSETS
Total Short-Term Assets $78.91M
Total Long-Term Assets $46.33M
Total Assets $125.2M
YoY Change 5.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $17.10M
YoY Change 9.75%
Accrued Expenses $6.535M
YoY Change 1.26%
Deferred Revenue $7.859M
YoY Change 6.84%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $44.56M
YoY Change 5.99%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $3.954M
YoY Change 37.29%
Total Long-Term Liabilities $3.954M
YoY Change 37.29%
TOTAL LIABILITIES
Total Short-Term Liabilities $44.56M
Total Long-Term Liabilities $3.954M
Total Liabilities $54.95M
YoY Change 4.53%
SHAREHOLDERS EQUITY
Retained Earnings -$128.7M
YoY Change 0.19%
Common Stock $199.0M
YoY Change 1.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $70.28M
YoY Change
Total Liabilities & Shareholders Equity $125.2M
YoY Change 5.79%

Cashflow Statement

Concept 2024 Q3 2024 Q2

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 dei Entity Central Index Key
EntityCentralIndexKey
0000350868
CY2024Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2024Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
1250 S. Capital of Texas Hwy., Building 1
CY2024Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 330
CY2024Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Austin
CY2024Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2024Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
95-2588496
CY2024Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
78746
CY2024Q2 dei City Area Code
CityAreaCode
512
CY2024Q2 dei Local Phone Number
LocalPhoneNumber
382-9669
CY2024Q2 dei Security12b Title
Security12bTitle
Common Stock, $0.10 par value
CY2024Q2 dei Trading Symbol
TradingSymbol
ITI
CY2024Q2 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q2 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2024Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q2 dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
42822824 shares
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21377000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25850000 usd
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
248000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
125000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
281000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
351000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
30635000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7237000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8791000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
9602000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
28340000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
28340000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1039000 usd
CY2024Q2 us-gaap Assets
Assets
125235000 usd
CY2024Q1 us-gaap Assets
Assets
123445000 usd
CY2024Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
17100000 usd
CY2024Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
15852000 usd
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
13070000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12812000 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6535000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6596000 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7859000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8070000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
44564000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
43330000 usd
CY2024Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
538000 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
515000 usd
CY2024Q2 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
39000 usd
CY2024Q1 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
39000 usd
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3954000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3444000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
54952000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
53538000 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
392000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
65807000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6827000 usd
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43006000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42972000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42972000 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
4301000 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
4298000 usd
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
194695000 usd
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
194093000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-128684000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-128469000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
70283000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
69907000 usd
CY2024Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q2 dei Amendment Flag
AmendmentFlag
false
CY2024Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
CY2024Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q2 dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
CY2024Q2 dei Entity Registrant Name
EntityRegistrantName
ITERIS, INC.
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
25672000 usd
CY2024Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
8386000 usd
CY2024Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
7271000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
14841000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
13432000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3418000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3581000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
78905000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
75931000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1288000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1296000 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1084000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5857000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6210000 usd
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43006000 shares
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
125235000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
123445000 usd
CY2024Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
815000 usd
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
673000 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y6M7D
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y10M24D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.050
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.047
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1931000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2436000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2498000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1447000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
293000 usd
CY2024Q2 iti Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
188000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
8793000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
760000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
8033000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2176000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5857000 usd
CY2024Q2 iti Share Based Compensation Number Of Stock Incentive Plans
ShareBasedCompensationNumberOfStockIncentivePlans
2 plan
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
6200000 shares
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
595000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
525000 usd
CY2020Q4 iti Deferred Compensation Share Based Arrangements Number Of Plans
DeferredCompensationShareBasedArrangementsNumberOfPlans
2 plan
CY2024Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2024Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
CY2024Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
CY2024Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
29000 usd
CY2024Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
15000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
45777000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
43545000 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
28437000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
26742000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
17340000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
16803000 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6306000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5801000 usd
CY2024Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7250000 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6290000 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2880000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2108000 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
651000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
651000 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
17087000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
14850000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
253000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1953000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
56000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
199000 usd
CY2024Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
131000 usd
CY2023Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
68000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
440000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2220000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
95000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
392000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2125000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42969000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42567000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43970000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43640000 shares
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2125000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
539000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
511000 usd
CY2024Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
23000 usd
CY2023Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
22000 usd
CY2024Q2 us-gaap Depreciation
Depreciation
135000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
150000 usd
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
595000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
525000 usd
CY2024Q2 iti Amortization Of Intangible Assets Including Cost Of Sales
AmortizationOfIntangibleAssetsIncludingCostOfSales
982000 usd
CY2023Q2 iti Amortization Of Intangible Assets Including Cost Of Sales
AmortizationOfIntangibleAssetsIncludingCostOfSales
783000 usd
CY2024Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4963000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1620000 usd
CY2024Q2 iti Increase Decrease In Unbilled Receivables And Deferred Revenue Net
IncreaseDecreaseInUnbilledReceivablesAndDeferredRevenueNet
816000 usd
CY2023Q2 iti Increase Decrease In Unbilled Receivables And Deferred Revenue Net
IncreaseDecreaseInUnbilledReceivablesAndDeferredRevenueNet
-687000 usd
CY2024Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1409000 usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
693000 usd
CY2024Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-118000 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1182000 usd
CY2024Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1268000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3354000 usd
CY2024Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-482000 usd
CY2023Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-616000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3618000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4046000 usd
CY2024Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24000 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
168000 usd
CY2024Q2 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
97000 usd
CY2023Q2 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
588000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-121000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-756000 usd
CY2024Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10000 usd
CY2023Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
257000 usd
CY2024Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
CY2023Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6000 usd
CY2024Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
621000 usd
CY2023Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-611000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
251000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4350000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3541000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25975000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16727000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21625000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20268000 usd
CY2024Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
129000 usd
CY2023Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
121000 usd
CY2024Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
103000 usd
CY2023Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 usd
CY2024Q2 iti Capitalized Computer Software Costs Incurred But Not Yet Paid
CapitalizedComputerSoftwareCostsIncurredButNotYetPaid
74000 usd
CY2023Q2 iti Capitalized Computer Software Costs Incurred But Not Yet Paid
CapitalizedComputerSoftwareCostsIncurredButNotYetPaid
234000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
69907000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
595000 usd
CY2024Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
621000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
392000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
70283000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
62906000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
257000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-6000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
525000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2125000 usd
CY2024Q2 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of unaudited financial statements in conformity with GAAP requires our management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Significant estimates made in the preparation of the financial statements include, but are not limited to, recoverability of long-lived and intangible assets; estimates of future cash flows used to assess the recoverability of the impairment of goodwill; projections of taxable income used to assess realizability of deferred tax assets; warranty reserves; costs to complete long-term contracts; indirect cost rates used in cost plus contracts; fair value of stock option awards and equity instruments; and capitalization and estimated useful life of the Company’s internal-use software development costs. Estimates are based on historical experience and on various assumptions that the Company believes are reasonable under current circumstances. However, future events are subject to change and best estimates and judgments may require further adjustments, therefore, actual results could differ materially from those estimates. Management periodically evaluates such estimates, and they are adjusted prospectively based upon such periodic evaluation.</span></div>
CY2024Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
400000 usd
CY2024Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
500000 usd
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
4000000.0 usd
CY2024Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3400000 usd
CY2024Q2 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to a concentration of credit risk consist principally of cash and cash equivalents and trade accounts receivable.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist primarily of demand deposits and money market funds maintained with two financial institutions. Deposits held with banks may exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and are maintained with high quality financial institutions, and therefore are believed to have minimal credit risk. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. As of June 30, 2024, the Company had approximately $21.1 million of deposits at financial institutions in excess of the FDIC insured limit. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accounts receivable are primarily derived from billings with customers located throughout North America. We generally do not require collateral or other security from our North American customers. We maintain an allowance for credit losses, which losses have historically been within management’s expectations.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have, and historically have had, a diverse customer base. For the three months ended June 30, 2024 and 2023, no individual customer represented greater than 10% of our total revenues. As of June 30, 2024 and March 31, 2024, no individual customer represented greater than 10% of our total accounts receivable.</span></div>
CY2024Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
21100000 usd
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
200000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
100000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21377000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19994000 usd
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
248000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
274000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21625000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20268000 usd
CY2024Q2 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
11514000 usd
CY2024Q1 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
9063000 usd
CY2024Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
185000 usd
CY2024Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
468000 usd
CY2024Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3142000 usd
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3901000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
14841000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
13432000 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6538000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6403000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1288000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1296000 usd
CY2024Q2 us-gaap Depreciation
Depreciation
100000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
200000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
25676000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16885000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8791000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
25505000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15902000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
9602000 usd
CY2024Q2 iti Amortization Of Intangible Assets Including Cost Of Sales
AmortizationOfIntangibleAssetsIncludingCostOfSales
1000000.0 usd
CY2023Q2 iti Amortization Of Intangible Assets Including Cost Of Sales
AmortizationOfIntangibleAssetsIncludingCostOfSales
800000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2586000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2359000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2036000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1295000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
503000 usd
CY2024Q2 iti Finite Lived Intangible Assets Net Excluding Trade Names
FiniteLivedIntangibleAssetsNetExcludingTradeNames
8779000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
28300000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
28300000 usd
CY2024Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
813000 usd
CY2023Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
758000 usd
CY2024Q2 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
48000 usd
CY2023Q2 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
193000 usd
CY2024Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
5000 usd
CY2023Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
96000 usd
CY2024Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
856000 usd
CY2023Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
855000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
392000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2125000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42969000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42567000 shares
CY2024Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1001000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1073000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43970000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43640000 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2024Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
0 usd
CY2024Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
0 usd
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.109
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
100000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.043
CY2023Q2 iti Loss Contingency Gain In Period Inventory To Be Returned
LossContingencyGainInPeriodInventoryToBeReturned
1000000 usd
CY2023Q2 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
200000 usd
CY2023Q2 iti Loss Contingency Loss In Period Inventory Sale Amount
LossContingencyLossInPeriodInventorySaleAmount
1000000 usd
CY2023Q3 iti Loss Contingency Gain In Period Inventory To Be Returned
LossContingencyGainInPeriodInventoryToBeReturned
800000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6827000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7237000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6827000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7237000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2176000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2233000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5857000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6210000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
8033000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
8443000 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
600000 usd
CY2024Q2 us-gaap Lease Cost
LeaseCost
600000 usd
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
iti-20240630_cal.xml Edgar Link unprocessable
0000350868-24-000025-index-headers.html Edgar Link pending
0000350868-24-000025-index.html Edgar Link pending
0000350868-24-000025.txt Edgar Link pending
0000350868-24-000025-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
iti-20240630.htm Edgar Link pending
iti-20240630.xsd Edgar Link pending
iti-20240630x10xqceoex311.htm Edgar Link pending
iti-20240630x10xqceoex321.htm Edgar Link pending
iti-20240630x10xqcfoex312.htm Edgar Link pending
iti-20240630x10xqcfoex322.htm Edgar Link pending
iti-20240630_g1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
iti-20240630_lab.xml Edgar Link unprocessable
iti-20240630_def.xml Edgar Link unprocessable
iti-20240630_htm.xml Edgar Link completed
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
iti-20240630_pre.xml Edgar Link unprocessable